Patient P-03136
Therapy response
Declining
Tolerance
Favorable
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
17%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 ONX-7 started — Baseline state S11
- Day 34 HY-01 recommended — Hydration Protocol HY-01
- Day 35 Patient accepted — Started HY-01 in the companion
- Day 39 No meaningful change — Hydration Protocol HY-01
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- Inflammatory activity-11
- Nutritional resilience+11
- Treatment adherence+7
- GI instability-6
- Toxicity-3
What helped?
- Hydration Protocol HY-01Day 34Result: no meaningful change
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Energy level
Daily log5.9/10
stable · -0.1 vs previous 14 d
Stress level
Daily log4.3/10
worsening · +0.3 vs previous 14 d
Pessimism score
Daily log4.2/10
worsening · +0.3 vs previous 14 d
Sleep quality
Wearable42.5/100
stable · -0.9 vs previous 14 d
Libido
Daily log4.6/10
worsening · -0.2 vs previous 14 d
HRV
Wearable49.5 ms
worsening · -1.9 vs previous 14 d
Toxicity
Blood23.3/100
worsening · +2.8 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards restoration · 68 from the failing basin, 24 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
- More proteinGI -3.3 next day on high-intake days · n 19
Would not help
- HY-01 Hydration Protocolalready tried, no meaningful change
- AD-05 Adherence Supportonly 29% improved among 14 similar
- Keep lactose lowGI +3.1 next day on high-intake days · n 20
- Keep caffeine lowGI +2.1 next day on high-intake days · n 19
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-3.3supporter · 95%
- Lactose+3.1detractor · 95%
- Caffeine+2.1detractor · 75%
- Histamine load-1no signal · 32%
- Dietary fat load-0.2no signal · 15%
- Alcohol-0.2no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Drug metabolism and exposure ↑40
- DNACYP2D6 poor metabolizer → higher exposure
- Inflammatory signalling ↓25
- DNAIL6 -174 variant raises baseline inflammatory tone
DNA
Fictional pharmacogenomic panel
- IL6 -174 G/CHigher inflammatory tone
- CYP2D6 Poor metabolizerHigher exposure at standard dose
Microbiome
Shannon diversity 2.8 · butyrate capacity 56/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisNormal
- Bifidobacterium longumLow
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 45 ms
- Sleep
- 6.6 h
- Steps
- 4,449
- Resting HR
- 72 bpm
Daily log: GI score 25, nutritional resilience 66, adherence 96.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- A 15-minute walk after lunch
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.